According to a study published in the journal 'eBioMedicine', adults who stay hydrated seem to be fitter as they develop fewer chronic conditions such as heart and lung disease, and live longer than those who may not get enough fluids.
According to a National Institutes of Health study published in eBioMedicine, adults who stay hydrated appear to be healthier, develop fewer chronic conditions such as heart and lung disease, and live longer than those who may not get enough fluids.
New Delhi [India], December 16 (ANI/PRNewswire): The India Fashion Awards 2022, presented by Rajnigandha Pearls oared by Mario foods, was held at Andaz by Hyatt to celebrate innovators in the fashion industry. The who's who of fashion across the country were present at the gala night to eith
The company's total income (or total revenue) for Q2 FY23 was Rs 22,409 million, an increase of 5.1 per cent over Q2 FY22. The company in a statement said its adjusted operating profit or earnings before interest, taxes, depreciation, and amortisation (Ebitda) for Q2 FY23 was Rs 18,209 milli
New Delhi [India], November 16 (ANI/PRNewswire): Orchid Pharma today announced their Q2'22 results. Fuelled by increasing sales and a laser-sharp focus on costs, Orchid Pharma reported a 36 per cent surge in total revenue from operations while the EBIDTA has jumped by 104 per cent over the q
Mumbai (Maharashtra) [India], November 15 (ANI/PNN): SVP Global Textiles Ltd, one of the largest compact cotton yarn manufacturers and leading multinational textiles company has reported a Total Income from Operations of Rs 294.1 crore for the quarter ended September 2022, rise of 4.9 per ce
Bengaluru (Karnataka) [India], November 15 (ANI/NewsVoir): Biocon Ltd, an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the second quarter ended September 30, 2022.
The New Delhi-headquartered company said its operating profit and Earnings before interest, taxes, depreciation, and amortisation (Ebitda) grew 74.1 per cent to Rs 88.4 crore in the reviewed quarter, against Rs 50.8 crore in the year-ago period.
The pharmaceutical firm's net revenue went down 3.4 per cent to Rs 5,739 crore against Rs 5,941 crore in the corresponding period the previous year.
Net Ebitda of the company went down 33 per cent to Rs 790 crore against Rs 1,186 crore in the year-ago period.
The Hyderabad-headquartered firm said its revenues grew 52.48 per cent to Rs 1,683.07 crore on a year-on-year basis. The company also said operating profit or Ebitda also rose 45.07 per cent YoY.
The company has seen a stronger monetisation across all its key businesses while limiting indirect costs, leading to a 61 per cent YoY improvement in operating profits or Ebitda before employee stock ownership plan (ESOP) costs to Rs 166 crore.